OVER / UNDER
KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Price history — Before 2028

Last 7 days of market YES price (blue) with the fair-price range (orange).

85¢0¢25¢50¢75¢100¢Wed 5/20Thu 5/21Fri 5/22Sat 5/23Sun 5/24TODAY
━ market YES▬ fair range
Market price
Before 2028★ BEST85¢
Before October 202777¢
Before July 202769¢
Before Mar 1, 202736¢
Before Jan 1, 202717¢
Kalshi • Volume: 8.8K contracts • Updated 4h agoCloses: 2028-01-01
Kalshi · Science and Technology
OU's Pick
YES · Before 2028
at 85¢
Price gap
Kalshi85¢
→
OU's fair85¢
Confidence
Moderate

Compass Pathways is targeting a rolling NDA submission in late 2026 with potential approval by early 2027 following positive Phase 3 results and breakthrough therapy status.

Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.